397
Views
41
CrossRef citations to date
0
Altmetric
Original papers

In vitro susceptibility of campylobacter and salmonella isolates from broilers to quinolones, ampicillin, tetracycline, and erythromycin

, , &
Pages 206-208 | Published online: 01 Nov 2011
 

Summary

Recently, an increased resistance of Campylobacter to fluoroquinolones, a newer class of antimicrobial agents in both human and veterinary medicine, has been reported. Campylobacter isolates (617) from 150 broiler flocks were tested for their susceptibility to cephalothin (control), ampicillin, tetracycline, erythromycin, and the quinolones nalidixic acid, flumequine, enrofloxacin, and ciprofloxacin by a disc diffusion method. Almost complete cross‐resistance was found between the quinolones tested. Campylobacter isolates (181, 29%), originating from 55 flocks (37%), were quinolone resistant.

Salmonella isolates (94) from 40 flocks were also tested for their antimicrobial susceptibility. Eight isolates (8.5%), from three broiler flocks (7.5%), showed resistance to nalidixic acid and flumequine (and tetracycline), but not to ciprofloxacin or enrofloxacin.

Notes

Institute for Animal Science and Health (1D‐DLO). Branch Beekbergen, Spelderholt 9, 7361 DA Beekbergen, the Netherlands.

Wageningen Agricultural University, Department of Food Science, Bomenweg 2, 6703 HD Wageningen, the Netherlands.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.